The global medical industry experienced a 25% drop in new job postings related to robotics in Q1 2023 compared with the previous quarter, according to GlobalData’s Job Analytics. This compares to a 29% decrease versus Q1 2022. GlobalData’s Robotics in Healthcare – Thematic Intelligence market report provides a detailed understanding of how Robotics impacts the value chain in the Medical Devices sector, and the leading robotics adopters and vendors in the market. Buy the report here.
Notably, Architecture and Engineering Occupations jobs accounted for an 18% share of the global medical industry’s robotics-related total new job postings in Q1 2023, down 22% over the prior quarter.
Architecture and Engineering Occupations drive robotics-related hiring activity
Architecture and Engineering Occupations, with a share of 18%, emerged as the top robotics-related job roles within the medical industry in Q1 2023, with new job postings drop by 22% quarter-on-quarter. Installation, Maintenance, and Repair Occupations came in second with a share of 16% in Q1 2023, with new job postings dropping by 16% over the previous quarter.
The other prominent robotics roles include Computer and Mathematical Occupations with an 11% share in Q1 2023, Management Occupations with a 9% share of new job postings.
Top five companies in medical industry accounted for 44% of hiring activity
The top companies, in terms of number of new job postings tracked by GlobalData, as of Q1 2023 were West Pharmaceutical Services, Zimmer Biomet, Stryker, Medtronic, and Danaher. Together they accounted for a combined share of 44% of all robotics-related new jobs in the medical industry.
West Pharmaceutical Services posted 166 robotics-related new jobs in Q1 2023, Zimmer Biomet 138 jobs, Stryker 111 jobs, Medtronic 77 jobs, and Danaher 64 jobs, according to GlobalData’s Job Analytics.
Hiring activity was driven by the US with a 78.93% share of total new job postings, Q1 2023
The largest share of robotics-related new job postings in the medical industry in Q1 2023 was in the US with 78.93% followed by Australia (2.92%) and France (2.60%). The share represented by the US was four percentage points lower than the 82.55% share it accounted for in Q4 2022.
To further understand GlobalData's analysis on Robotics in Healthcare - Thematic Intelligence buy the report here.